Biophage Pharma appoints two new members to the Board of Directors



    MONTREAL, July 16 /CNW Telbec/ - (TSX.V: BUG). Biophage Pharma is pleased
to announce the appointment of Mr. Luc Dubois and Mr. Jocelyn R. Pelchat to
its Board of Directors. Mr. Dubois is the President of the Board of Validapro
Biosciences Inc. Mr. Dubois is a biologist expert in the pharmaceutical and
biotechnological fields. He has a deep knowledge of the key players and market
trends, and is an internationally recognized specialist from process
development to commercial product manufacturing, including in laboratory
requirements for (bio) pharmaceutical products. Mr. Dubois also holds an
executive MBA in Bio-industries and a B.Sc. in Biology with major in
Physico-Toxicology.
    Mr. Pelchat is the Vice-president of Pharma Concept Inc. Mr. Pelchat is a
chemist, holds an executive MBA and a M.Sc. in Nuclear medicine/Radiobiology.
He is a senior Executive with international Pharma experience. He served in a
number of executive, business development and management positions with Axcan
Pharma Inc., SGF (Société Générale de Financement), Sanofi Aventis and
Novartis.

    About Biophage Pharma Inc.

    Biophage is a Canadian biotechnology company focused on the development
of innovative phage-based products and technologies for the detection,
prevention and control of bacterial infections. Biophage operates two
divisions: (1) The Biosensors division for the development and
commercialization of Biosensors PDS(R); and (2) The Therapeutics division for
the prevention and control of bacterial contaminations in the medical,
veterinary and environment fields. The two programs have been structured to
deliver an environmentally safe solution for the early detection and rapid
control of deadly microorganisms. (www.biophagepharma.net.)

    The TSX Venture Exchange does not accept responsibility for the adequacy
    or accuracy of this release.




For further information:

For further information: Rosemonde Mandeville, M.B., Ch.B., PhD.,
President and CEO, Biophage Pharma Inc., (514) 496-1488,
rosemonde.mandeville@biophagepharma.net

Organization Profile

BIOPHAGE PHARMA, INC.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890